Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,286.00
(
0.64%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.61
(
-0.04%
)
Bitcoin
73,977.60
(
0.05%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: rkrw post# 108174

Friday, 07/27/2012 10:36:02 AM

Friday, July 27, 2012 10:36:02 AM

Post# of 257253
Lupin could be first US filer for generic Advair:

http://articles.economictimes.indiatimes.com/2012-07-26/news/32869722_1_vinita-gupta-lupin-pharma-generic-drug

This is a tricky approval to pull off because of the need to replicate the device as well as the drug; NVS and Teva both gave up on such a project despite the lure of Advair’s huge US sales.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now